{"id":"W2030267719","doi":"10.3747/co.19.959","title":"Re. Karam I, Melosky B. Response to Second-Line Erlotinib in an EGFR Mutation-Negative Patient with Non-Small-Cell Lung Cancer: Make No Assumptions","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Erlotinib; Medicine; Epidermal growth factor receptor; Tyrosine kinase; Lung cancer; Gefitinib; Cancer research; Mutation; Second line; Statement (logic); Oncology; First line; Internal medicine; Cancer; Receptor; Genetics; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005160622,0.0005427552,0.001688609,0.001285833,0.0009465926,0.001482677,0.002823995,0.0120879,0.004407821],"category_scores_gemma":[0.06006019,0.0004981537,0.001192293,0.001008538,0.001536703,0.002750412,0.0007070535,0.01816973,0.009787702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002036894,"about_ca_system_score_gemma":0.002706354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006571873,"about_ca_topic_score_gemma":0.01307226,"domain_scores_codex":[0.9974016,0.0005484525,0.000576985,0.0003071076,0.0009429434,0.000222841],"domain_scores_gemma":[0.9620378,0.01375962,0.00166402,0.00104668,0.01980356,0.001688173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"case_report","study_design_scores_codex":[0.0002469075,0.00002953302,0.001941282,0.0001669941,0.00008327443,0.001271257,0.0001123196,0.0001764758,0.0002947724,0.001403427,0.9574462,0.03682774],"study_design_scores_gemma":[0.0004507266,0.0003233109,0.01420862,0.002911796,0.000522704,0.006660152,0.0006460512,0.001281817,0.001734832,0.01252095,0.9583182,0.0004207842],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.001466083,0.0174861,0.0007979722,0.8822255,0.09104492,0.00003150256,0.0002867808,0.00007052017,0.006590527],"genre_scores_gemma":[0.01967398,0.02202299,0.001484132,0.8243224,0.1163514,0.00007725033,0.0003585223,0.0001049163,0.01560443],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0120879,"threshold_uncertainty_score":0.02729225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04993453140751817,"score_gpt":0.4229905339288198,"score_spread":0.3730560025213016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}